Melanoma

Challenging Cases in BRAF-Mutated Melanoma: Applying the Latest Advances to Optimize Care

Challenging Cases in BRAF-Mutated Melanoma: Applying the Latest Advances to Optimize Care

Advances in BRAF-targeted agents and their integration into treatment algo…

Expiration Date: 12/21/2022

Max Credits: 1

View Activity

Keeping an Eye Out: Emerging Trends in the Management of Metastatic Uveal Melanoma

Keeping an Eye Out: Emerging Trends in the Management of Metastatic Uveal Melanoma

Uveal melanoma is the most common ocular cancer, typically affecting older…

Expiration Date: 12/21/2022

Max Credits: 0.75

View Activity

Rapid-Fire Roundtable on Melanoma: Focus on Advances in Adjuvant Treatment, Neoadjuvant Treatment, and Management of Metastatic Disease

Rapid-Fire Roundtable on Melanoma: Focus on Advances in Adjuvant Treatment, Neoadjuvant Treatment, and Management of Metastatic Disease

Treatment for patients with advanced melanoma has been revolutionized thro…

Expiration Date: 12/21/2022

Max Credits: 0.75

View Activity

Real-World Insights From Individuals With Lung Cancer in the Context of a Digital Health Coaching Program

Real-World Insights From Individuals With Lung Cancer in the Context of a Digital Health Coaching Program

Lung cancer continues to be the major cause of cancer-related deaths world…

Expiration Date: 12/21/2021

Max Credits: 0

View Activity

Optimizing Outcomes For Patients With Lung Cancer: Checkpoint Inhibitor Therapy in SCLC and Improving Health Literacy

Optimizing Outcomes For Patients With Lung Cancer: Checkpoint Inhibitor Therapy in SCLC and Improving Health Literacy

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 10/6/2021

Max Credits: 0

View Activity

Optimizing Outcomes For Patients With Lung Cancer: Checkpoint Inhibitor Therapy in NSCLC, Patient Coaching, and Evaluation of Patient Reported Outcomes

Optimizing Outcomes For Patients With Lung Cancer: Checkpoint Inhibitor Therapy in NSCLC, Patient Coaching, and Evaluation of Patient Reported Outcomes

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 8/16/2021

Max Credits: 0

View Activity

Checkpoint Inhibitors as First-line Treatments for Lung Cancer: What You Need to Know

Checkpoint Inhibitors as First-line Treatments for Lung Cancer: What You Need to Know

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 6/29/2021

Max Credits: 0

View Activity

Clinical Advances and Emerging Trends in Melanoma: A Symposium at the Society for Melanoma Research 2019 Congress

Clinical Advances and Emerging Trends in Melanoma: A Symposium at the Society for Melanoma Research 2019 Congress

In this educational activity, experts in the field review the patient, dis…

Expiration Date: 3/18/2021

Max Credits: 0

View Activity

Melanoma—BRAF-Mutated Disease, Checkpoint Inhibitors, Emerging Trends, and Challenging Cases

Melanoma—BRAF-Mutated Disease, Checkpoint Inhibitors, Emerging Trends, and Challenging Cases

In this educational activity, experts in the field review the patient, dis…

Expiration Date: 3/16/2021

Max Credits: 0

View Activity

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

For patients diagnosed with metastatic melanoma, the lifetime incidence of…

Expiration Date: 4/30/2020

Max Credits: 0

View Activity